# Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone

> **NCT00947895** · PHASE2,PHASE3 · TERMINATED · sponsor: **Neurologique Foundation, Inc.** · enrollment: 30 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** ACTH
- **OTHER:** IV placebo
- **OTHER:** IM placebo

## Key facts

- **NCT ID:** NCT00947895
- **Lead sponsor:** Neurologique Foundation, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-10
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 30 (ACTUAL)
- **Why stopped:** Study reached halfway point in approximately one year time period and was halted to analyze data.
- **Last updated:** 2016-03-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00947895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00947895, "Efficacy Study of Adrenocorticotropin Hormone to Treat Multiple Sclerosis (MS) Relapses After Sub-responding to an Initial 3 Day Course of Intravenous (IV) Methylprednisolone". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00947895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*